+关注
qachenzude
暂无个人介绍
IP属地：福建
70
关注
0
粉丝
2
主题
0
勋章
主贴
热门
qachenzude
2020-06-04
有了解的吗？是否值得申购
金斯瑞生物科技(01548)：传奇生物拟发行1842.5万股新美国存托股份
qachenzude
2020-06-04
传奇生物 ，有了解的吗
金斯瑞生物科技(01548)：传奇生物拟发行1842.5万股新美国存托股份
qachenzude
2020-04-15
持股的股票怎么处理？
聚美优品宣布完成私有化交易，正式从纽交所退市
qachenzude
2016-11-04
怎么交易不了了
$TetraLogic医药(TLOG)$怎么交易不了了
怎么交易不了了
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"118794540219192","uuid":"118794540219192","gmtCreate":1459249157846,"gmtModify":1459305828377,"name":"qachenzude","pinyin":"qachenzude","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","hatId":"ca_profile_frame_Mpy1eK","hatName":"","vip":1,"status":2,"fanSize":0,"headSize":70,"tweetSize":4,"questionSize":0,"limitLevel":900,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":2,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":8,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.99%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"02aa7f16703b4ce4ace6f1a7665789cc-1","templateUuid":"02aa7f16703b4ce4ace6f1a7665789cc","name":"知识体验官","description":"观看学堂课程满5节","bigImgUrl":"https://static.tigerbbs.com/fb5ae275631fb96a92d475cdc85d2302","smallImgUrl":"https://static.tigerbbs.com/c2660a1935bd2105e97c9915619936c3","grayImgUrl":null,"redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.08.05","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":2006},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.03.23","exceedPercentage":"80.33%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.17","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001}],"userBadgeCount":6,"currentWearingBadge":{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.03.23","exceedPercentage":"80.50%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},"individualDisplayBadges":null,"crmLevel":3,"crmLevelSwitch":1,"location":"福建","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":2,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":958872548,"gmtCreate":1591242979084,"gmtModify":1704194965979,"author":{"id":"118794540219192","authorId":"118794540219192","name":"qachenzude","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"118794540219192","idStr":"118794540219192"},"themes":[],"htmlText":"有了解的吗？是否值得申购","listText":"有了解的吗？是否值得申购","text":"有了解的吗？是否值得申购","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/958872548","repostId":"2039241207","repostType":2,"repost":{"id":"2039241207","kind":"highlight","pubTimestamp":1590764843,"share":"https://www.laohu8.com/m/news/2039241207?lang=zh_CN&edition=full","pubTime":"2020-05-29 23:07","market":"hk","language":"zh","title":"金斯瑞生物科技(01548)：传奇生物拟发行1842.5万股新美国存托股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2039241207","media":"智通财经网","summary":"金斯瑞生物科技(01548)发布公告，就内容有关建议分拆传奇生物科技股份有限公司并...","content":"<html><body><article>\n<p>智通财经APP讯，<a href=\"https://laohu8.com/S/01548\">金斯瑞生物科技</a>(01548)发布公告，就内容有关建议分拆传奇生物科技股份有限公司并在纳斯达克全球市场独立上市的相关事宜。</p><p>公告称，传奇生物已于2020年5月29日(纽约时间)就其价格区间为18.00美元至20.00美元的美国存托股份向证交会提交注册声明。受传奇生物及承销商订立的承销协议的最终条款规限及视乎市况而定，发售预计将包括由传奇生物首次公开发售出售的1842.5万股新美国存托股份。承销商亦将可选择购买最多达276.375万股额外美国存托股份以补足超额分配。每股美国存托股份将代表两股传奇<a href=\"https://laohu8.com/S/600201\">生物股份</a>。</p><p>在发售完成的前提下，于发售完成时，传奇生物将按经调整以反映美国存托股份对普通股比率的每股公开发售价向本公司发行及出售一定数目的传奇生物股份，总价为1200万美元(同时私人配售)。</p><p>假设超额配股权未获行使及假设发售价定为每股美国存托股份19.00美元，估计传奇生物发售所得款项净额将约为3.22亿美元。约1.6亿美元至1.85亿美元将用于LCAR-B38M/JNJ-4528的临床开发;约6000万美元至7500万美元将用于建设生产车间;约1500万美元至2000万美元将用于LCAR-B38M/JNJ-4528的商业化;及约4190万美元至8690万美元将用于发展管线以及营运资金及其他一般企业用途。</p> </article></body></html>","source":"highlight_zhitongcaijin","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>金斯瑞生物科技(01548)：传奇生物拟发行1842.5万股新美国存托股份</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n金斯瑞生物科技(01548)：传奇生物拟发行1842.5万股新美国存托股份\n</h2>\n\n<h4 class=\"meta\">\n\n\n2020-05-29 23:07 北京时间 <a href=http://www.zhitongcaijing.com/content/detail/305930.html><strong>智通财经网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，金斯瑞生物科技(01548)发布公告，就内容有关建议分拆传奇生物科技股份有限公司并在纳斯达克全球市场独立上市的相关事宜。公告称，传奇生物已于2020年5月29日(纽约时间)就其价格区间为18.00美元至20.00美元的美国存托股份向证交会提交注册声明。受传奇生物及承销商订立的承销协议的最终条款规限及视乎市况而定，发售预计将包括由传奇生物首次公开发售出售的1842.5万股新美国存托...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/305930.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_29.jpeg?x-oss-process=image/format,jpg/quality,Q_100/resize,h_300","relate_stocks":{"01548":"金斯瑞生物科技","LEGN":"传奇生物"},"source_url":"http://www.zhitongcaijing.com/content/detail/305930.html","is_english":false,"share_image_url":"https://static.laohu8.com/6ca2dcdccfa2217fb20a0351f4efe814","article_id":"2039241207","content_text":"智通财经APP讯，金斯瑞生物科技(01548)发布公告，就内容有关建议分拆传奇生物科技股份有限公司并在纳斯达克全球市场独立上市的相关事宜。公告称，传奇生物已于2020年5月29日(纽约时间)就其价格区间为18.00美元至20.00美元的美国存托股份向证交会提交注册声明。受传奇生物及承销商订立的承销协议的最终条款规限及视乎市况而定，发售预计将包括由传奇生物首次公开发售出售的1842.5万股新美国存托股份。承销商亦将可选择购买最多达276.375万股额外美国存托股份以补足超额分配。每股美国存托股份将代表两股传奇生物股份。在发售完成的前提下，于发售完成时，传奇生物将按经调整以反映美国存托股份对普通股比率的每股公开发售价向本公司发行及出售一定数目的传奇生物股份，总价为1200万美元(同时私人配售)。假设超额配股权未获行使及假设发售价定为每股美国存托股份19.00美元，估计传奇生物发售所得款项净额将约为3.22亿美元。约1.6亿美元至1.85亿美元将用于LCAR-B38M/JNJ-4528的临床开发;约6000万美元至7500万美元将用于建设生产车间;约1500万美元至2000万美元将用于LCAR-B38M/JNJ-4528的商业化;及约4190万美元至8690万美元将用于发展管线以及营运资金及其他一般企业用途。","news_type":1,"symbols_score_info":{"LEGN":0.9,"01548":1}},"isVote":1,"tweetType":1,"viewCount":2247,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":958872280,"gmtCreate":1591242953840,"gmtModify":1704194965806,"author":{"id":"118794540219192","authorId":"118794540219192","name":"qachenzude","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"118794540219192","idStr":"118794540219192"},"themes":[],"htmlText":"传奇生物 ，有了解的吗","listText":"传奇生物 ，有了解的吗","text":"传奇生物 ，有了解的吗","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/958872280","repostId":"2039241207","repostType":2,"repost":{"id":"2039241207","kind":"highlight","pubTimestamp":1590764843,"share":"https://www.laohu8.com/m/news/2039241207?lang=zh_CN&edition=full","pubTime":"2020-05-29 23:07","market":"hk","language":"zh","title":"金斯瑞生物科技(01548)：传奇生物拟发行1842.5万股新美国存托股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2039241207","media":"智通财经网","summary":"金斯瑞生物科技(01548)发布公告，就内容有关建议分拆传奇生物科技股份有限公司并...","content":"<html><body><article>\n<p>智通财经APP讯，<a href=\"https://laohu8.com/S/01548\">金斯瑞生物科技</a>(01548)发布公告，就内容有关建议分拆传奇生物科技股份有限公司并在纳斯达克全球市场独立上市的相关事宜。</p><p>公告称，传奇生物已于2020年5月29日(纽约时间)就其价格区间为18.00美元至20.00美元的美国存托股份向证交会提交注册声明。受传奇生物及承销商订立的承销协议的最终条款规限及视乎市况而定，发售预计将包括由传奇生物首次公开发售出售的1842.5万股新美国存托股份。承销商亦将可选择购买最多达276.375万股额外美国存托股份以补足超额分配。每股美国存托股份将代表两股传奇<a href=\"https://laohu8.com/S/600201\">生物股份</a>。</p><p>在发售完成的前提下，于发售完成时，传奇生物将按经调整以反映美国存托股份对普通股比率的每股公开发售价向本公司发行及出售一定数目的传奇生物股份，总价为1200万美元(同时私人配售)。</p><p>假设超额配股权未获行使及假设发售价定为每股美国存托股份19.00美元，估计传奇生物发售所得款项净额将约为3.22亿美元。约1.6亿美元至1.85亿美元将用于LCAR-B38M/JNJ-4528的临床开发;约6000万美元至7500万美元将用于建设生产车间;约1500万美元至2000万美元将用于LCAR-B38M/JNJ-4528的商业化;及约4190万美元至8690万美元将用于发展管线以及营运资金及其他一般企业用途。</p> </article></body></html>","source":"highlight_zhitongcaijin","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>金斯瑞生物科技(01548)：传奇生物拟发行1842.5万股新美国存托股份</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n金斯瑞生物科技(01548)：传奇生物拟发行1842.5万股新美国存托股份\n</h2>\n\n<h4 class=\"meta\">\n\n\n2020-05-29 23:07 北京时间 <a href=http://www.zhitongcaijing.com/content/detail/305930.html><strong>智通财经网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，金斯瑞生物科技(01548)发布公告，就内容有关建议分拆传奇生物科技股份有限公司并在纳斯达克全球市场独立上市的相关事宜。公告称，传奇生物已于2020年5月29日(纽约时间)就其价格区间为18.00美元至20.00美元的美国存托股份向证交会提交注册声明。受传奇生物及承销商订立的承销协议的最终条款规限及视乎市况而定，发售预计将包括由传奇生物首次公开发售出售的1842.5万股新美国存托...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/305930.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_29.jpeg?x-oss-process=image/format,jpg/quality,Q_100/resize,h_300","relate_stocks":{"01548":"金斯瑞生物科技","LEGN":"传奇生物"},"source_url":"http://www.zhitongcaijing.com/content/detail/305930.html","is_english":false,"share_image_url":"https://static.laohu8.com/6ca2dcdccfa2217fb20a0351f4efe814","article_id":"2039241207","content_text":"智通财经APP讯，金斯瑞生物科技(01548)发布公告，就内容有关建议分拆传奇生物科技股份有限公司并在纳斯达克全球市场独立上市的相关事宜。公告称，传奇生物已于2020年5月29日(纽约时间)就其价格区间为18.00美元至20.00美元的美国存托股份向证交会提交注册声明。受传奇生物及承销商订立的承销协议的最终条款规限及视乎市况而定，发售预计将包括由传奇生物首次公开发售出售的1842.5万股新美国存托股份。承销商亦将可选择购买最多达276.375万股额外美国存托股份以补足超额分配。每股美国存托股份将代表两股传奇生物股份。在发售完成的前提下，于发售完成时，传奇生物将按经调整以反映美国存托股份对普通股比率的每股公开发售价向本公司发行及出售一定数目的传奇生物股份，总价为1200万美元(同时私人配售)。假设超额配股权未获行使及假设发售价定为每股美国存托股份19.00美元，估计传奇生物发售所得款项净额将约为3.22亿美元。约1.6亿美元至1.85亿美元将用于LCAR-B38M/JNJ-4528的临床开发;约6000万美元至7500万美元将用于建设生产车间;约1500万美元至2000万美元将用于LCAR-B38M/JNJ-4528的商业化;及约4190万美元至8690万美元将用于发展管线以及营运资金及其他一般企业用途。","news_type":1,"symbols_score_info":{"LEGN":0.9,"01548":1}},"isVote":1,"tweetType":1,"viewCount":1426,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":926003236,"gmtCreate":1586916948325,"gmtModify":1704362517441,"author":{"id":"118794540219192","authorId":"118794540219192","name":"qachenzude","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"118794540219192","idStr":"118794540219192"},"themes":[],"htmlText":"持股的股票怎么处理？","listText":"持股的股票怎么处理？","text":"持股的股票怎么处理？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/926003236","repostId":"1114531386","repostType":4,"repost":{"id":"1114531386","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1586916401,"share":"https://www.laohu8.com/m/news/1114531386?lang=zh_CN&edition=full","pubTime":"2020-04-15 10:06","market":"us","language":"zh","title":"聚美优品宣布完成私有化交易，正式从纽交所退市","url":"https://stock-news.laohu8.com/highlight/detail?id=1114531386","media":"老虎资讯综合","summary":"4月15日，聚美优品宣布完成私有化，成为买方团拥有的私人控股公司，将正式从纽交所退市。\n1月12日，聚美优品买方团提起私有化要约，拟用每ADS 20美元的价格收购未持有的股份。经一个多月的谈判，买方团","content":"<p>4月15日，<a href=\"https://laohu8.com/S/JMEI\">聚美优品</a>宣布完成私有化，成为买方团拥有的私人控股公司，将正式从纽交所退市。</p>\n<p>1月12日，聚美优品买方团提起私有化要约，拟用每ADS 20美元的价格收购未持有的股份。经一个多月的谈判，买方团与聚美优品达成最终收购方案。</p>\n<p>4月9日，买方团通过要约收购方式收购了超过4034万股A类普通股，约占流通中聚美优品已发行A类普通股总量的63.7%，至此，聚美优品买方团已持有上市公司约96%的投票权，正式启动简易合并。</p>\n<p>4月15日私有化交易完成，聚美优品结束为期六年的美股上市生涯。</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>聚美优品宣布完成私有化交易，正式从纽交所退市</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n聚美优品宣布完成私有化交易，正式从纽交所退市\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2020-04-15 10:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>4月15日，<a href=\"https://laohu8.com/S/JMEI\">聚美优品</a>宣布完成私有化，成为买方团拥有的私人控股公司，将正式从纽交所退市。</p>\n<p>1月12日，聚美优品买方团提起私有化要约，拟用每ADS 20美元的价格收购未持有的股份。经一个多月的谈判，买方团与聚美优品达成最终收购方案。</p>\n<p>4月9日，买方团通过要约收购方式收购了超过4034万股A类普通股，约占流通中聚美优品已发行A类普通股总量的63.7%，至此，聚美优品买方团已持有上市公司约96%的投票权，正式启动简易合并。</p>\n<p>4月15日私有化交易完成，聚美优品结束为期六年的美股上市生涯。</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/017a2d51f9605f643f552ed0e3997176","relate_stocks":{"JMEI":"聚美优品"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1114531386","content_text":"4月15日，聚美优品宣布完成私有化，成为买方团拥有的私人控股公司，将正式从纽交所退市。\n1月12日，聚美优品买方团提起私有化要约，拟用每ADS 20美元的价格收购未持有的股份。经一个多月的谈判，买方团与聚美优品达成最终收购方案。\n4月9日，买方团通过要约收购方式收购了超过4034万股A类普通股，约占流通中聚美优品已发行A类普通股总量的63.7%，至此，聚美优品买方团已持有上市公司约96%的投票权，正式启动简易合并。\n4月15日私有化交易完成，聚美优品结束为期六年的美股上市生涯。","news_type":1,"symbols_score_info":{"JMEI":0.9}},"isVote":1,"tweetType":1,"viewCount":2653,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":34685,"gmtCreate":1478267663523,"gmtModify":1704873839743,"author":{"id":"118794540219192","authorId":"118794540219192","name":"qachenzude","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"118794540219192","idStr":"118794540219192"},"themes":[],"title":"怎么交易不了了","htmlText":"$TetraLogic医药(TLOG)$怎么交易不了了","listText":"$TetraLogic医药(TLOG)$怎么交易不了了","text":"$TetraLogic医药(TLOG)$怎么交易不了了","images":[],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":2,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/34685","isVote":1,"tweetType":1,"viewCount":3750,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":34685,"gmtCreate":1478267663523,"gmtModify":1704873839743,"author":{"id":"118794540219192","authorId":"118794540219192","name":"qachenzude","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"118794540219192","idStr":"118794540219192"},"themes":[],"title":"怎么交易不了了","htmlText":"$TetraLogic医药(TLOG)$怎么交易不了了","listText":"$TetraLogic医药(TLOG)$怎么交易不了了","text":"$TetraLogic医药(TLOG)$怎么交易不了了","images":[],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":2,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/34685","isVote":1,"tweetType":1,"viewCount":3750,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":926003236,"gmtCreate":1586916948325,"gmtModify":1704362517441,"author":{"id":"118794540219192","authorId":"118794540219192","name":"qachenzude","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"118794540219192","idStr":"118794540219192"},"themes":[],"htmlText":"持股的股票怎么处理？","listText":"持股的股票怎么处理？","text":"持股的股票怎么处理？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/926003236","repostId":"1114531386","repostType":4,"repost":{"id":"1114531386","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1586916401,"share":"https://www.laohu8.com/m/news/1114531386?lang=zh_CN&edition=full","pubTime":"2020-04-15 10:06","market":"us","language":"zh","title":"聚美优品宣布完成私有化交易，正式从纽交所退市","url":"https://stock-news.laohu8.com/highlight/detail?id=1114531386","media":"老虎资讯综合","summary":"4月15日，聚美优品宣布完成私有化，成为买方团拥有的私人控股公司，将正式从纽交所退市。\n1月12日，聚美优品买方团提起私有化要约，拟用每ADS 20美元的价格收购未持有的股份。经一个多月的谈判，买方团","content":"<p>4月15日，<a href=\"https://laohu8.com/S/JMEI\">聚美优品</a>宣布完成私有化，成为买方团拥有的私人控股公司，将正式从纽交所退市。</p>\n<p>1月12日，聚美优品买方团提起私有化要约，拟用每ADS 20美元的价格收购未持有的股份。经一个多月的谈判，买方团与聚美优品达成最终收购方案。</p>\n<p>4月9日，买方团通过要约收购方式收购了超过4034万股A类普通股，约占流通中聚美优品已发行A类普通股总量的63.7%，至此，聚美优品买方团已持有上市公司约96%的投票权，正式启动简易合并。</p>\n<p>4月15日私有化交易完成，聚美优品结束为期六年的美股上市生涯。</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>聚美优品宣布完成私有化交易，正式从纽交所退市</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n聚美优品宣布完成私有化交易，正式从纽交所退市\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2020-04-15 10:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>4月15日，<a href=\"https://laohu8.com/S/JMEI\">聚美优品</a>宣布完成私有化，成为买方团拥有的私人控股公司，将正式从纽交所退市。</p>\n<p>1月12日，聚美优品买方团提起私有化要约，拟用每ADS 20美元的价格收购未持有的股份。经一个多月的谈判，买方团与聚美优品达成最终收购方案。</p>\n<p>4月9日，买方团通过要约收购方式收购了超过4034万股A类普通股，约占流通中聚美优品已发行A类普通股总量的63.7%，至此，聚美优品买方团已持有上市公司约96%的投票权，正式启动简易合并。</p>\n<p>4月15日私有化交易完成，聚美优品结束为期六年的美股上市生涯。</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/017a2d51f9605f643f552ed0e3997176","relate_stocks":{"JMEI":"聚美优品"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1114531386","content_text":"4月15日，聚美优品宣布完成私有化，成为买方团拥有的私人控股公司，将正式从纽交所退市。\n1月12日，聚美优品买方团提起私有化要约，拟用每ADS 20美元的价格收购未持有的股份。经一个多月的谈判，买方团与聚美优品达成最终收购方案。\n4月9日，买方团通过要约收购方式收购了超过4034万股A类普通股，约占流通中聚美优品已发行A类普通股总量的63.7%，至此，聚美优品买方团已持有上市公司约96%的投票权，正式启动简易合并。\n4月15日私有化交易完成，聚美优品结束为期六年的美股上市生涯。","news_type":1,"symbols_score_info":{"JMEI":0.9}},"isVote":1,"tweetType":1,"viewCount":2653,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":958872548,"gmtCreate":1591242979084,"gmtModify":1704194965979,"author":{"id":"118794540219192","authorId":"118794540219192","name":"qachenzude","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"118794540219192","idStr":"118794540219192"},"themes":[],"htmlText":"有了解的吗？是否值得申购","listText":"有了解的吗？是否值得申购","text":"有了解的吗？是否值得申购","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/958872548","repostId":"2039241207","repostType":2,"repost":{"id":"2039241207","kind":"highlight","pubTimestamp":1590764843,"share":"https://www.laohu8.com/m/news/2039241207?lang=zh_CN&edition=full","pubTime":"2020-05-29 23:07","market":"hk","language":"zh","title":"金斯瑞生物科技(01548)：传奇生物拟发行1842.5万股新美国存托股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2039241207","media":"智通财经网","summary":"金斯瑞生物科技(01548)发布公告，就内容有关建议分拆传奇生物科技股份有限公司并...","content":"<html><body><article>\n<p>智通财经APP讯，<a href=\"https://laohu8.com/S/01548\">金斯瑞生物科技</a>(01548)发布公告，就内容有关建议分拆传奇生物科技股份有限公司并在纳斯达克全球市场独立上市的相关事宜。</p><p>公告称，传奇生物已于2020年5月29日(纽约时间)就其价格区间为18.00美元至20.00美元的美国存托股份向证交会提交注册声明。受传奇生物及承销商订立的承销协议的最终条款规限及视乎市况而定，发售预计将包括由传奇生物首次公开发售出售的1842.5万股新美国存托股份。承销商亦将可选择购买最多达276.375万股额外美国存托股份以补足超额分配。每股美国存托股份将代表两股传奇<a href=\"https://laohu8.com/S/600201\">生物股份</a>。</p><p>在发售完成的前提下，于发售完成时，传奇生物将按经调整以反映美国存托股份对普通股比率的每股公开发售价向本公司发行及出售一定数目的传奇生物股份，总价为1200万美元(同时私人配售)。</p><p>假设超额配股权未获行使及假设发售价定为每股美国存托股份19.00美元，估计传奇生物发售所得款项净额将约为3.22亿美元。约1.6亿美元至1.85亿美元将用于LCAR-B38M/JNJ-4528的临床开发;约6000万美元至7500万美元将用于建设生产车间;约1500万美元至2000万美元将用于LCAR-B38M/JNJ-4528的商业化;及约4190万美元至8690万美元将用于发展管线以及营运资金及其他一般企业用途。</p> </article></body></html>","source":"highlight_zhitongcaijin","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>金斯瑞生物科技(01548)：传奇生物拟发行1842.5万股新美国存托股份</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n金斯瑞生物科技(01548)：传奇生物拟发行1842.5万股新美国存托股份\n</h2>\n\n<h4 class=\"meta\">\n\n\n2020-05-29 23:07 北京时间 <a href=http://www.zhitongcaijing.com/content/detail/305930.html><strong>智通财经网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，金斯瑞生物科技(01548)发布公告，就内容有关建议分拆传奇生物科技股份有限公司并在纳斯达克全球市场独立上市的相关事宜。公告称，传奇生物已于2020年5月29日(纽约时间)就其价格区间为18.00美元至20.00美元的美国存托股份向证交会提交注册声明。受传奇生物及承销商订立的承销协议的最终条款规限及视乎市况而定，发售预计将包括由传奇生物首次公开发售出售的1842.5万股新美国存托...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/305930.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_29.jpeg?x-oss-process=image/format,jpg/quality,Q_100/resize,h_300","relate_stocks":{"01548":"金斯瑞生物科技","LEGN":"传奇生物"},"source_url":"http://www.zhitongcaijing.com/content/detail/305930.html","is_english":false,"share_image_url":"https://static.laohu8.com/6ca2dcdccfa2217fb20a0351f4efe814","article_id":"2039241207","content_text":"智通财经APP讯，金斯瑞生物科技(01548)发布公告，就内容有关建议分拆传奇生物科技股份有限公司并在纳斯达克全球市场独立上市的相关事宜。公告称，传奇生物已于2020年5月29日(纽约时间)就其价格区间为18.00美元至20.00美元的美国存托股份向证交会提交注册声明。受传奇生物及承销商订立的承销协议的最终条款规限及视乎市况而定，发售预计将包括由传奇生物首次公开发售出售的1842.5万股新美国存托股份。承销商亦将可选择购买最多达276.375万股额外美国存托股份以补足超额分配。每股美国存托股份将代表两股传奇生物股份。在发售完成的前提下，于发售完成时，传奇生物将按经调整以反映美国存托股份对普通股比率的每股公开发售价向本公司发行及出售一定数目的传奇生物股份，总价为1200万美元(同时私人配售)。假设超额配股权未获行使及假设发售价定为每股美国存托股份19.00美元，估计传奇生物发售所得款项净额将约为3.22亿美元。约1.6亿美元至1.85亿美元将用于LCAR-B38M/JNJ-4528的临床开发;约6000万美元至7500万美元将用于建设生产车间;约1500万美元至2000万美元将用于LCAR-B38M/JNJ-4528的商业化;及约4190万美元至8690万美元将用于发展管线以及营运资金及其他一般企业用途。","news_type":1,"symbols_score_info":{"LEGN":0.9,"01548":1}},"isVote":1,"tweetType":1,"viewCount":2247,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":958872280,"gmtCreate":1591242953840,"gmtModify":1704194965806,"author":{"id":"118794540219192","authorId":"118794540219192","name":"qachenzude","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"118794540219192","idStr":"118794540219192"},"themes":[],"htmlText":"传奇生物 ，有了解的吗","listText":"传奇生物 ，有了解的吗","text":"传奇生物 ，有了解的吗","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/958872280","repostId":"2039241207","repostType":2,"repost":{"id":"2039241207","kind":"highlight","pubTimestamp":1590764843,"share":"https://www.laohu8.com/m/news/2039241207?lang=zh_CN&edition=full","pubTime":"2020-05-29 23:07","market":"hk","language":"zh","title":"金斯瑞生物科技(01548)：传奇生物拟发行1842.5万股新美国存托股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2039241207","media":"智通财经网","summary":"金斯瑞生物科技(01548)发布公告，就内容有关建议分拆传奇生物科技股份有限公司并...","content":"<html><body><article>\n<p>智通财经APP讯，<a href=\"https://laohu8.com/S/01548\">金斯瑞生物科技</a>(01548)发布公告，就内容有关建议分拆传奇生物科技股份有限公司并在纳斯达克全球市场独立上市的相关事宜。</p><p>公告称，传奇生物已于2020年5月29日(纽约时间)就其价格区间为18.00美元至20.00美元的美国存托股份向证交会提交注册声明。受传奇生物及承销商订立的承销协议的最终条款规限及视乎市况而定，发售预计将包括由传奇生物首次公开发售出售的1842.5万股新美国存托股份。承销商亦将可选择购买最多达276.375万股额外美国存托股份以补足超额分配。每股美国存托股份将代表两股传奇<a href=\"https://laohu8.com/S/600201\">生物股份</a>。</p><p>在发售完成的前提下，于发售完成时，传奇生物将按经调整以反映美国存托股份对普通股比率的每股公开发售价向本公司发行及出售一定数目的传奇生物股份，总价为1200万美元(同时私人配售)。</p><p>假设超额配股权未获行使及假设发售价定为每股美国存托股份19.00美元，估计传奇生物发售所得款项净额将约为3.22亿美元。约1.6亿美元至1.85亿美元将用于LCAR-B38M/JNJ-4528的临床开发;约6000万美元至7500万美元将用于建设生产车间;约1500万美元至2000万美元将用于LCAR-B38M/JNJ-4528的商业化;及约4190万美元至8690万美元将用于发展管线以及营运资金及其他一般企业用途。</p> </article></body></html>","source":"highlight_zhitongcaijin","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>金斯瑞生物科技(01548)：传奇生物拟发行1842.5万股新美国存托股份</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n金斯瑞生物科技(01548)：传奇生物拟发行1842.5万股新美国存托股份\n</h2>\n\n<h4 class=\"meta\">\n\n\n2020-05-29 23:07 北京时间 <a href=http://www.zhitongcaijing.com/content/detail/305930.html><strong>智通财经网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，金斯瑞生物科技(01548)发布公告，就内容有关建议分拆传奇生物科技股份有限公司并在纳斯达克全球市场独立上市的相关事宜。公告称，传奇生物已于2020年5月29日(纽约时间)就其价格区间为18.00美元至20.00美元的美国存托股份向证交会提交注册声明。受传奇生物及承销商订立的承销协议的最终条款规限及视乎市况而定，发售预计将包括由传奇生物首次公开发售出售的1842.5万股新美国存托...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/305930.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_29.jpeg?x-oss-process=image/format,jpg/quality,Q_100/resize,h_300","relate_stocks":{"01548":"金斯瑞生物科技","LEGN":"传奇生物"},"source_url":"http://www.zhitongcaijing.com/content/detail/305930.html","is_english":false,"share_image_url":"https://static.laohu8.com/6ca2dcdccfa2217fb20a0351f4efe814","article_id":"2039241207","content_text":"智通财经APP讯，金斯瑞生物科技(01548)发布公告，就内容有关建议分拆传奇生物科技股份有限公司并在纳斯达克全球市场独立上市的相关事宜。公告称，传奇生物已于2020年5月29日(纽约时间)就其价格区间为18.00美元至20.00美元的美国存托股份向证交会提交注册声明。受传奇生物及承销商订立的承销协议的最终条款规限及视乎市况而定，发售预计将包括由传奇生物首次公开发售出售的1842.5万股新美国存托股份。承销商亦将可选择购买最多达276.375万股额外美国存托股份以补足超额分配。每股美国存托股份将代表两股传奇生物股份。在发售完成的前提下，于发售完成时，传奇生物将按经调整以反映美国存托股份对普通股比率的每股公开发售价向本公司发行及出售一定数目的传奇生物股份，总价为1200万美元(同时私人配售)。假设超额配股权未获行使及假设发售价定为每股美国存托股份19.00美元，估计传奇生物发售所得款项净额将约为3.22亿美元。约1.6亿美元至1.85亿美元将用于LCAR-B38M/JNJ-4528的临床开发;约6000万美元至7500万美元将用于建设生产车间;约1500万美元至2000万美元将用于LCAR-B38M/JNJ-4528的商业化;及约4190万美元至8690万美元将用于发展管线以及营运资金及其他一般企业用途。","news_type":1,"symbols_score_info":{"LEGN":0.9,"01548":1}},"isVote":1,"tweetType":1,"viewCount":1426,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}
